- Ana Sayfa
- Uygulama Analitiği
- Coexisting Diseases & Surgery
- Coexisting Diseases & Surgery Vs. Pedi Crisis 2.0
Coexisting Diseases & Surgery vs Pedi Crisis 2.0 Kullanım & İstatistikleri
A comprehensive medical disease app that contains the following:
1) Gives the description, etiology, onset, diagnosis, pathophysiology, treatment, and prognosis of common and rare diseases.
2) Provides specific information how to manage the surgical patient’s coexisting disease(s) perioperatively, and what the disease related concerns are.
One-time purchase with free updates.
This app is equivalent to a 4,000 page book and will always be expanded with frequent updates.
Categories:
Brain/Neuro
Cardiac
Hematologic Disorders
GI System
Endocrine System
Liver and Biliary Tract
Pediatrics
Renal Disease
Pulmonary
Congenital Heart Disease (coming soon)
- Apple App Store
- Ücretliler
- Medikal
Mağaza Sıralaması
- -
The Society for Pediatric Anesthesia (SPA) presents Pedi Crisis 2.0! This app contains peer-reviewed algorithms for treating 26 pediatric crisis situations. As an interactive version of the SPA critical event checklists, crucial details for these 26 pediatric critical events are now just a ‘tap’ away on your pocket device!
Quick reference drug dosage summaries are available for each emergency. Enter the patient’s weight to automatically calculate patient-specific dosages.
- Apple App Store
- BOŞTA
- Medikal
Mağaza Sıralaması
- -
Coexisting Diseases & Surgery ile Pedi Crisis 2.0 için sıralama karşılaştırması
Son 28 gündeki Coexisting Diseases & Surgery sıralama trendini Pedi Crisis 2.0ile karşılaştırın
Coexisting Diseases & Surgery#81
Rank
Coexisting Diseases & Surgery vs. Pedi Crisis 2.0 ülke karşılaştırmasına göre sıralama
Son 28 gündeki Coexisting Diseases & Surgery sıralama trendini Pedi Crisis 2.0ile karşılaştırın
Tüm kategoriler
Mevcut veri yok
Medikal
Uygulama
En İyi Ülke
Sıralama
#81
#74
Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın
Coexisting Diseases & Surgery VS.
Pedi Crisis 2.0
Aralık 11, 2024